MedTrace Logo

Effects of Whey Protein in Type 2 Diabetics

NCT01944449 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-10-11

No results posted yet for this study

Summary

The objectives of this study are to examine the effects of chronic, (12 weeks) administration of Whey protein on HbA1c, and postprandial glucose (PPG).

Conditions

Interventions

DIETARY_SUPPLEMENT

Whey Protein (WPC) at breakfast

The type 2 diabetic subjects in Whey Protein (WPC) group will consume at breakfast WPC (35 g) in 250ml of milk, Total 42 g protein breakfast for 12 weeks.

DIETARY_SUPPLEMENT

Other Protein Sources at breakfast

The type 2 diabetic subjects in PBdiet will consume also 42 g of protein but from different sources : i.e soy,tuna, eggs, at breakfast in bottle mixed with 250 ml water twice a day (30 min before breakfast and before dinner) for 12 weeks.

DIETARY_SUPPLEMENT

Low Protein at breakfast

The type 2 diabetic subjects in CBdiet group will consume only 17 g protein, namely from at breakfast for 12 weeks.

Sponsors & Collaborators

  • Hospital de Clinicas Caracas

    collaborator OTHER

  • Tel Aviv University

    lead OTHER

Principal Investigators

  • Julio Wainstein, MD · Head of Diabetes Unit E. Wolfson Medical Center Israel

  • Daniela Jakubowicz, MD · Hospital de Clinicas Caracas, Venezuela

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-02-29
Completion
2016-03-31

Countries

  • Israel
  • Venezuela

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01944449 on ClinicalTrials.gov